BASEIMMUNE

• 72110 - Research and experimental development on biotechnology

Baseimmune is a discovery-phase biotech start-up focused on antigen discovery and vaccine development. Baseimmune's technology harnesses pathogen and epidemiological big data combined with biological expertise to devise a robust method for antigen discovery, one of the major roadblocks in vaccine development. By streamlining the antigen selection process, we can develop better vaccines and empower agriculture and public health to stop emerging dangerous pathogens from spreading... Baseimmune is currently partnering with a number of leading academic institutions, pharmaceutical companies and vaccine manufacturers to design and develop vaccines across a range of diseases... Baseimmune is creating the next generation of universal future-proof vaccines for human and animal health. The company's proprietary deep learning technology uses innovative and powerful technology to generate completely new vaccines to target diseases that have previously been hard to protect against, as well as..

Also known as: BASEIMMUNE LTD

Registration numbers: 12289125 (CH)

Primary location: London United Kingdom